KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Non Operating Investment Income: 2018-2020

Historic Non Operating Investment Income for Aurinia Pharmaceuticals (AUPH) over the last 1 years, with Sep 2020 value amounting to $124,000.

  • Aurinia Pharmaceuticals' Non Operating Investment Income was N/A to $124,000 in Q3 2020 from the same period last year, while for Sep 2020 it was $128,000, marking a year-over-year change of. This contributed to the annual value of -$78,000 for FY2017, which is N/A change from last year.
  • As of Q3 2020, Aurinia Pharmaceuticals' Non Operating Investment Income stood at $124,000, which was up 12,300.00% from $1,000 recorded in Q2 2019.
  • Aurinia Pharmaceuticals' 5-year Non Operating Investment Income high stood at $124,000 for Q3 2020, and its period low was -$1,000 during Q3 2018.
  • Its 3-year average for Non Operating Investment Income is $23,167, with a median of $4,500 in 2018.
  • Data for Aurinia Pharmaceuticals' Non Operating Investment Income shows a maximum YoY slumped of 80.00% (in 2019) over the last 5 years.
  • Aurinia Pharmaceuticals' Non Operating Investment Income (Quarterly) stood at -$1,000 in 2018, then plummeted by 80.00% to $1,000 in 2019, then reached $124,000 in 2020.
  • Its last three reported values are $124,000 in Q3 2020, $1,000 for Q2 2019, and $4,000 during Q1 2019.